AI probing overheated oven on Dreamliner

Comments 0
SummaryAn oven in a Boeing Dreamliner operated by Air India overheated during a domestic flight this week causing smoke but did not interrupt services, the Indian carrier said, adding an investigation has begun.

An oven in a Boeing Dreamliner operated by Air India overheated during a domestic flight this week causing smoke but did not interrupt services, the Indian carrier said, adding an investigation has begun. The aviation regulator said it was examining the incident and had sought a report from Air India. The overheating did not cause a fire, an Air India spokesman said, adding they were in touch with Boeing over the issue. “Prima facie we feel that it’s something to do with the oven, not with the machine (plane) as such,” Arun Mishra, who heads India’s civil aviation regulator, said over phone, but added he can comment further only after getting the investigation report.

Piramal Healthcare arm to invest $2.5 m at UK site

Piramal’s Healthcare vertical will invest $2.5 million at its USFDA approved Grangemouth, UK, site to upgrade one of its antibody drug conjugate (ADC) manufacturing suites, from clinical phase to commercial grade, in response to customer demand. The upgrade will give Piramal two commercial grade ADC suites at the Grangemouth facility, while retaining clinical phase manufacturing capacity in other suites on site. Piramal’s Healthcare is a part of the Piramal Enterprises. As part of the investment, the areas supporting the manufacturing suite will also be upgraded to provide new areas for buffer preparation and equipment preparation.

RPG Life Sciences net increases to R55 crore

Pharmaceutical firm RPG Life Sciences has reported a net profit of R54.69 crore for the quarter ended June. The company had posted a net profit of R2.79 crore during the same period of previous fiscal. Net sales of the company rose to R62.9 crore during the quarter against R54.7 crore during the corresponding quarter of last year. The company said it has received a notice of non-compliance from US Food and Drug Administration during the quarter. “The company has duly responded to the said notice, however, there is no immediate business impact of this event as the company does not have any exports to US,” the company said in a press release filed to BSE.

Tata Coffee Q1 net up 43% at R40.38 crore

Tata Coffee on Friday

Single Page Format
Ads by Google

More from Front Page

Reader´s Comments
| Post a Comment
Please Wait while comments are loading...